Conservative surgery in patients with multifocal/multicentric breast cancer

被引:93
作者
Gentilini, Oreste [1 ]
Botteri, Edoardo [2 ]
Rotmensz, Nicole [2 ]
Da Lima, Luciana [1 ]
Caliskan, Mujgan [1 ]
Garcia-Etienne, Carlos A. [1 ]
Sosnovskikh, Irina [1 ]
Intra, Mattia [1 ]
Mazzarol, Giovanni [3 ]
Musmeci, Simona [1 ]
Veronesi, Paolo [1 ,4 ]
Galimberti, Viviana [1 ]
Luini, Alberto [1 ]
Viale, Giuseppe [1 ,4 ]
Goldhirsch, Aron [5 ]
Veronesi, Umberto [1 ]
机构
[1] European Inst Oncol, Div Breast Surg, I-20141 Milan, Italy
[2] European Inst Oncol, Div Epidemiol & Biostat, I-20141 Milan, Italy
[3] European Inst Oncol, Div Pathol & Lab Med, I-20141 Milan, Italy
[4] Univ Milan, Sch Med, European Inst Oncol, Milan, Italy
[5] European Inst Oncol, Dept Med, I-20141 Milan, Italy
关键词
Conservative surgery; Breast cancer; Quadrantectomy; Multifocal; Multicentric; RADIATION-THERAPY; MASTECTOMY;
D O I
10.1007/s10549-008-9959-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose Many physicians recommend mastectomy in case of multifocal (MF) or multicentric (MC) breast cancer due to a theoretical risk of poor local control with less extensive surgery. We retrospectively evaluate outcome of patients with MF/MC cancers who had breast conservation with specific attention on local control and predictive factors of recurrence. Patients and methods Four hundred and seventy six patients with either MF (n = 421) or MC (n = 55) breast cancer, underwent breast-conserving surgery between 1997 and 2002 in a single institution. Median follow up was 73 months (range 11-118). Results Median age was 53 years (range 23-86). Invasive lobular carcinoma was found in 88 patients (18.5%) and mixed ductal-lobular cancer in 27 (5.7%) patients. Two hundred and sixty-seven patients (76.7%) had two identified tumor foci, 55 patients (15.3%) had three and 29 patients (8.0%) had four or more. Two hundred and sixty-one patients (55.3%) had nodal involvement. The 5-year cumulative incidence of local relapse was 5.1%. At the multivariate analysis, over-expression of HER2/neu and lack of both estrogen and progesterone receptors (HR: 3.2, 95% C.I. 1.01-10.0, and HR: 2.7, 95% C.I. 1.06-7.7, respectively) were associated with a higher ipsilateral breast cancer reappearance rate. Involvement of four or more lymph nodes and lack of estrogen and progesterone receptors (HR: 2.7, 95% C.I. 1.06-6.7, and HR: 4.7, 95% C.I. 2.1-10.4, respectively) were associated with poorer overall survival. Conclusions In selected patients with MF/MC breast cancer, wide conservative surgery is not associated with poor local disease control and can be considered whenever acceptable cosmetic results can be achieved.
引用
收藏
页码:577 / 583
页数:7
相关论文
共 21 条
[1]   Pathologic analysis of tumor size and lymph node status in multifocal/multicentric breast carcinoma [J].
Andea, AA ;
Wallis, T ;
Newman, LA ;
Bouwman, D ;
Dey, J ;
Visscher, DW .
CANCER, 2002, 94 (05) :1383-1390
[2]   Conservative surgery and radiation therapy for macroscopically multiple ipsilateral invasive breast cancers [J].
Cho, LC ;
Senzer, N ;
Peters, GN .
AMERICAN JOURNAL OF SURGERY, 2002, 183 (06) :650-654
[3]   Multifocal and multicentric breast cancer: Does each focus matter? [J].
Coombs, NJ ;
Boyages, J .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (30) :7497-7502
[4]   Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer [J].
Fisher, B ;
Anderson, S ;
Bryant, J ;
Margolese, RG ;
Deutsch, M ;
Fisher, ER ;
Jeong, J ;
Wolmark, N .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (16) :1233-1241
[5]   THE ROLE OF MASTECTOMY IN PATIENTS WITH STAGE I-II BREAST-CANCER PRESENTING WITH GROSS MULTIFOCAL OR MULTICENTRIC DISEASE OR DIFFUSE MICROCALCIFICATIONS [J].
FOWBLE, B ;
YEH, IT ;
SCHULTZ, DJ ;
SOLIN, LJ ;
ROSATO, EF ;
JARDINES, L ;
HOFFMAN, J ;
EISENBERG, B ;
WEISS, MC ;
HANKS, G .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 27 (03) :567-573
[6]   Sentinel lymph node biopsy in multicentric breast cancer.: The experience of the European Institute of Oncology [J].
Gentilini, O. ;
Trifiro, G. ;
Soteldo, J. ;
Luini, A. ;
Intra, M. ;
Galimberti, V. ;
Veronesi, P. ;
Silva, L. ;
Gandini, S. ;
Paganelli, G. ;
Veronesi, U. .
EJSO, 2006, 32 (05) :507-510
[7]   A CLASS OF K-SAMPLE TESTS FOR COMPARING THE CUMULATIVE INCIDENCE OF A COMPETING RISK [J].
GRAY, RJ .
ANNALS OF STATISTICS, 1988, 16 (03) :1141-1154
[8]   Specificity of HercepTest in determining HER-2/neu status of breast cancers using the united states food and drug administration-approved scoring system [J].
Jacobs, TW ;
Gown, AM ;
Yaziji, H ;
Barnes, MJ ;
Schnitt, SJ .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (07) :1983-1987
[9]   Breast conservation in patients with multiple ipsilateral synchronous cancers [J].
Kaplan, J ;
Giron, G ;
Tartter, PI ;
Bleiweiss, IJ ;
Estabrook, A ;
Smith, SR .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2003, 197 (05) :726-729
[10]   BREAST-CONSERVING THERAPY FOR MACROSCOPICALLY MULTIPLE CANCERS [J].
KURTZ, JM ;
JACQUEMIER, J ;
AMALRIC, R ;
BRANDONE, H ;
AYME, Y ;
HANS, D ;
BRESSAC, C ;
SPITALIER, JM .
ANNALS OF SURGERY, 1990, 212 (01) :38-44